Knowledge fractional co2 laser machine Which laser resurfacing modalities are recommended for managing residual atrophic scarring following hemangioma involution? Discover Fractional CO2 & Er:YAG options
Author avatar

Tech Team · Belislaser

Updated 1 month ago

Which laser resurfacing modalities are recommended for managing residual atrophic scarring following hemangioma involution? Discover Fractional CO2 & Er:YAG options


For residual atrophic scarring after hemangioma involution, the principal resurfacing options are fractional carbon dioxide (CO2) lasers and Erbium laser systems, particularly Er:YAG. These platforms create controlled microthermal or ablative treatment zones that stimulate dermal collagen remodeling, helping improve depressed contours and irregular skin texture. Persistent superficial telangiectasias are treated separately with a vascular laser rather than resurfacing alone.

Fractional CO2 and Er:YAG resurfacing are the main modalities for post-involution atrophic scars. The choice depends on scar depth, skin characteristics, treatment tolerance, and the presence of associated vascular changes.

Why Atrophic Scars Remain After Involution

Involution Can Leave Structural Defects

Although an infantile hemangioma may substantially regress, the skin does not always return to its original structure. Residual changes can include epidermal atrophy, depressed scarring, altered texture, fibrofatty tissue, and telangiectasia.

Surface Texture and Deeper Contour Are Different Problems

Laser resurfacing is most appropriate for superficial to moderate atrophic scarring and textural irregularity. A persistent deep fibrofatty mass creates a contour problem that may require surgical excision or liposuction rather than laser resurfacing.

Which Resurfacing Modalities Are Used?

Fractional CO2 Laser

Fractionated CO2 lasers deliver columns of controlled thermal injury while leaving untreated skin between treatment zones. This allows the surrounding tissue to support healing while stimulating collagen remodeling and resurfacing.

Fractional CO2 is generally suited to more pronounced textural irregularity or deeper atrophic scars, although treatment intensity must be individualized. The procedure can improve scar blending, surface smoothness, and depressed contour.

Erbium Laser Resurfacing

Erbium systems, particularly Er:YAG lasers, remove or remodel superficial layers with less residual thermal injury than CO2 systems. They can be useful when a practitioner seeks controlled resurfacing with potentially less thermal damage.

Er:YAG may be selected for more superficial scars, specific skin types, or patients for whom minimizing thermal exposure is important. The appropriate depth and treatment pattern remain more important than the device name alone.

Fractional Non-Ablative Lasers

Fractional non-ablative systems can stimulate dermal remodeling without removing the epidermis. They may be considered when a more conservative treatment course is preferred, but they typically provide less immediate resurfacing than ablative fractional CO2 or Er:YAG treatment.

The primary resurfacing choices described for post-hemangioma atrophic scarring remain fractional CO2 and Er:YAG systems. Non-ablative treatment is a potential alternative when the clinical situation favors lower downtime or a gentler approach.

Managing Associated Telangiectasia

Vascular Lasers Address Residual Redness

Atrophic scarring and superficial telangiectasia may coexist, but they require different laser targets. Vascular lasers, including pulsed dye laser or long-pulsed Nd:YAG systems selected according to vessel characteristics, target abnormal microvascular structures through selective photothermolysis.

Resurfacing should not be expected to reliably remove residual vascular discoloration. A staged or combined treatment plan may therefore use fractional resurfacing for texture and a vascular laser for persistent telangiectasia.

Treatment Order Depends on the Clinical Findings

The clinician may treat the scar and vascular component in separate sessions or coordinate them within a broader protocol. The sequence should account for scar depth, skin response, inflammation, and the risk of prolonged erythema or pigment alteration.

How Modality Selection Is Determined

Scar Depth and Surface Irregularity

Deeper or more sharply depressed atrophic scars may justify a stronger fractional ablative approach, such as fractional CO2. More superficial textural changes may be addressed with Er:YAG or a less aggressive fractional strategy.

Skin Type and Pigment Risk

The risk of post-inflammatory hyperpigmentation or hypopigmentation varies with skin type and treatment intensity. A qualified laser practitioner should adjust energy, density, and treatment intervals accordingly.

Scar Stability and Patient Age

Treatment is generally considered after the hemangioma has completed involution and the residual scar is clinically stable. In children, the decision must also account for cooperation, anesthesia requirements, healing capacity, and the psychosocial impact of the scar.

Understanding the Trade-offs

Ablative Treatment Requires Recovery

Fractional CO2 and Er:YAG treatments can produce redness, swelling, crusting, and temporary sensitivity. More aggressive treatment may improve pronounced scars more substantially, but it also increases downtime and the risk of adverse effects.

Results Develop Gradually

Laser resurfacing does not immediately replace atrophic tissue. Improvement occurs as the skin heals and collagen remodeling continues, and multiple treatment sessions may be required.

Resurfacing Has Limits

Laser treatment can improve texture and contour but may not fully eliminate a scar. It is also not the appropriate treatment for every residual abnormality, particularly a deep fibrofatty mass or a predominantly vascular lesion.

Abnormal Healing Requires Prompt Review

Increasing erythema with induration after resurfacing can indicate an exaggerated scar response. Early medical assessment is important because clinicians may consider corticosteroid treatment, silicone gel or sheeting, or other scar-directed interventions.

Patient-Specific Precautions Matter

Patients with a history of hypertrophic scarring or keloids require careful assessment before aggressive resurfacing. Treatment planning should also account for recent medications, including oral isotretinoin, and any factor that could impair healing.

Making the Right Choice for Your Goal

The most appropriate modality should be selected through examination of the residual lesion by a dermatologist or plastic surgeon experienced with pediatric and vascular laser treatment.

  • If your primary focus is improving depressed texture: Fractional CO2 or Er:YAG resurfacing is the relevant modality class, with treatment depth matched to scar severity.
  • If your primary focus is reducing residual redness or telangiectasia: A targeted vascular laser is more appropriate than resurfacing alone.
  • If your primary focus is correcting a deep residual contour: Seek assessment for surgical management, because resurfacing may not address fibrofatty tissue.
  • If your primary focus is minimizing downtime or pigment risk: Discuss a less aggressive fractional or non-ablative approach and accept that improvement may be more gradual or limited.

The key is to match the laser to the dominant residual problem: resurfacing for atrophic texture, vascular treatment for telangiectasia, and surgery for deep residual volume.

Summary Table:

Modality Indications Advantages Considerations
Fractional CO2 Deeper atrophic scars, pronounced textural irregularity Strong collagen remodeling, significant improvement Longer downtime, higher pigment risk
Er:YAG Superficial scars, skin types with higher pigment risk Less thermal damage, faster healing Less dramatic effect on deep scars
Fractional Non-ablative Conservative treatment, minimal downtime Lower risk, gentle stimulation Limited resurfacing effect, multiple sessions needed
Vascular lasers (PDL/Nd:YAG) Coexisting telangiectasia Target redness specifically Do not address textural scars

Partner with BELIS for Advanced Laser Solutions

At BELIS, we specialize in professional-grade medical aesthetic equipment for clinics and premium salons. Our portfolio includes fractional CO2 and Er:YAG lasers, as well as complete systems for vascular and aesthetic treatments. Whether you're a clinic expanding your services or a distributor seeking high-demand devices, we offer OEM/ODM support, certifications, and reliable supply to boost your business. Contact us today to explore how our technology can elevate your practice and drive growth.

Related Products

People Also Ask

Related Products

Fractional CO2 Laser Machine for Skin Treatment

Fractional CO2 Laser Machine for Skin Treatment

CO2 Fractional Laser Machine for skin resurfacing, scar removal & anti-aging. 40W/60W power, adjustable modes & minimal downtime. FDA-approved for safe treatments.

Fractional CO2 Laser Machine for Skin Treatment

Fractional CO2 Laser Machine for Skin Treatment

CO2 Fractional Laser Machine for skin rejuvenation, scar removal, and gynecological treatments. Dual-mode precision with customizable settings. Learn more now!


Leave Your Message